The island nation will use its own drug developed by top scientists in the Caribbean nation to improve the quality of life of patients.
Cuba will conduct a clinical trial with a drug developed in the island to work toward a more effective treatment for Alzheimer’s patients, another leading science breakthrough for the socialist nation, local media reported Monday.
See How Playing a Video Game Can Help Alzheimer’s Research
The drug NeuroEpo was developed by scientific institutions in Cuba, and its tests are expected to reduce the signs and side effects of the disease and improve patients’ quality of life.
The Center for Molecular Immunology in Havana will begin to apply the medicine to patients in the early stages of Alzheimer’s disease, according to research specialists cited by Granma.